Bidirectional Effects of Fentanyl on Dendritic Spines and AMPA Receptors Depend Upon the Internalization of Mu Opioid Receptors

Neuropsychopharmacology

Volumn 34, Issue 9, 2009, Pages 2097-2111

  Lin, Hang ^a,b   Higgins, Paul ^a   Loh, Horace H ^a   Law, Ping Yee ^a   Liao, Dezhi ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Chengdu Military General Hospital   (China)

Author keywords

AMPA receptors; Cognitive dysfunctions; Dendritic spines; Fentanyl; Receptor internalization

Indexed keywords

AMPA RECEPTOR; FENTANYL; MORPHINE; MU OPIATE RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOPHYSIN;

ANALGESIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITE; DENDRITIC SPINE; DRUG EFFECT; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANALGESICS, OPIOID; ANIMALS; CELL MEMBRANE; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM AGENTS; DENDRITIC SPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNAMIN I; FENTANYL; HIPPOCAMPUS; MUTATION, MISSENSE; NEURONS; PROTEIN TRANSPORT; RATS; RECEPTORS, AMPA; RECEPTORS, OPIOID, MU; SOMATOSTATIN; SYNAPSES;

EID: 67651115756     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.34     Document Type: Article

References (66)

1. Alvarez V, Arttamangkul S, Williams JT (2001). A RAVE about opioid withdrawal. Neuron 32: 761-763.
2. Alvarez VA, Arttamangkul S, Dang V, Salem A, Whistler JL, von Zastrow M et al (2002). m-Opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 22: 5769-5776.
3. Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ et al (1995). Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15: 3328-3341.
4. Biala G, Betancur C, Mansuy IM, Giros B (2005). The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin. Eur J Neurosci 21: 3089-3096.
5. Bliss TV, Collingridge GL (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39.
6. Bodnar RJ (2007). Endogenous opiates and behavior: 2006. Peptides 28: 2435-2513.
7. Bodnar RJ, Hadjimarkou MM (2003). Endogenous opiates and behavior: 2002. Peptides 24: 1241-1302.
8. Canli T, Cook RG, Miczek KA (1990). Opiate antagonists enhance the working memory of rats in the radial maze. Pharmacol Biochem Behav 36: 521-525.
9. Chu P, Murray S, Lissin D, von Zastrow M (1997). Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J Biol Chem 272: 27124-27130.
10. Cometta-Morini C, Maguire PA, Loew GH (1992). Molecular determinants of mu receptor recognition for the fentanyl class of compounds. Mol Pharmacol 41: 185-196.
11. Compton WM, Volkow ND (2005). Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 81: 103-107.
12. Ersche KD, Clark L, London M, Robbins TW, Sahakian BJ (2006). Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 31: 1036-1047.
13. Fan GH, Wang LZ, Qiu HC, Ma L, Pei G (1999). Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol Pharmacol 56: 39-45.
14. Finn AK, Whistler JL (2001). Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 32: 829-839.
15. Fodale V, Mafrica F, Santamaria LB, Coleman JJ (2008). Killer fentanyl: is the fear justified? Expert Opin Drug Saf 7: 213-217.
16. Gallagher M, Bostock E, King R (1985). Effects of opiate antagonists on spatial memory in young and aged rats. Behav Neural Biol 44: 374-385.
17. Goslin K, Banker Gin (1991). In: Banker G, Goslin K (eds). Culturing Nerve Cells. MIT Press: London. pp 251-283.
18. Gruber SA, Silveri MM, Yurgelun-Todd DA (2007). Neuropsychological consequences of opiate use. Neuropsychol Rev 17: 299-315.
19. Haberstock-Debic H, Kim KA, Yu YJ, von Zastrow M (2005). Morphine promotes rapid, arrestin-dependent endocytosis of m-opioid receptors in striatal neurons. J Neurosci 25: 7847-7857.
20. Haberstock-Debic H, Wein M, Barrot M, Colago EE, Rahman Z, Neve RL et al (2003). Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. J Neurosci 23: 4324-4332.
21. Hanks GW, Reid C (2005). Contribution to variability in response to opioids. Support Care Cancer 13: 145-152.
22. He L, Fong J, von Zastrow M, Whistler JL (2002). Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108: 271-282.
23. Hollmann M, Heinemann S (1994). Cloned glutamate receptors. Annu Rev Neurosci 17: 31-108.
24. Kalivas PW, Alesdatter JE (1993). Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267: 486-495.
25. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989). Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci 45: 599-606.
26. Kauer JA, Malenka RC (2007). Synaptic plasticity and addiction. Nat Rev Neurosci 8: 844-858.
27. Kronstrand R, Druid H, Holmgren P, Rajs J (1997). A cluster of fentanyl-related deaths among drug addicts in Sweden. Forensic Sci Int 88: 185-193.
28. Kelley AE (2004). Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 44: 161-179.
29. Kennedy MB (2000). Signal-processing machines at the postsynaptic density. Science 290: 750-754.
30. Lane DA, Lessard AA, Chan J, Colago EE, Zhou Y, Schlussman SD et al (2008). Region-specific changes in the subcellular distribution of AMPA receptor GluR1 sub unit in the rat ventral tegmental area after acute or chronic morphine administration. J Neurosci 28: 9670-9681.
31. Liao D, Grigoriants OO, Loh HH, Law PY (2007a). Agonist-dependent postsynaptic effects of opioids on miniature excitatory postsynaptic currents in cultured hippocampal neurons. J Neurophysiol 97: 1485-1494.
32. Liao D, Grigoriants OO, Wang W, Wiens K, Loh HH, Law PY (2007b). Distinct effects of individual opioids on the morphology of spines depend upon the internalization of mu opioid receptors. Mol Cell Neurosci 35: 456-469.
33. Liao D, Lin H, Law PY, Loh HH (2005). Mu-opioid receptors modulate the stability of dendritic spines. Proc Natl Acad Sci USA 102: 1725-1730.
34. Liao D, Scannevin RH, Huganir R (2001). Activation of silent synapses by rapid activity-dependent synaptic recruitment of AMPA receptors. J Neurosci 21: 6008-6017.
35. Liao D, Zhang X, O'Brien R, Ehlers MD, Huganir RL (1999). Regulation of morphological postsynaptic silent synapses in developing hippocampal neurons. Nat Neurosci 2: 37-43.
36. Lin H, Huganir R, Liao D (2004). Temporal dynamics of NMDA receptor-induced changes in spine morphology and AMPA receptor recruitment to spines. Biochem Biophys Res Commun 316: 501-511.
37. Malenka RC (1994). Synaptic plasticity in the hippocampus: LTP and LTD. Cell 78: 535-538.
38. Malinow R, Mainen ZF, Hayashi Y (2000). LTP mechanisms: from silence to four-lane traffic. Curr Opin Neurobiol 10: 352-357.
39. Mansour A, Fox CA, Akil H, Watson SJ (1995). Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18: 22-29.
40. Martin SJ, Grimwood PD, Morris RGM (2000). Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci 23: 649-711.
41. Martini L, Whistler JL (2007). The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Curr Opin Neurobiol 17: 556-564.
42. McNamara P (2002). Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care. Palliat Med 16: 425-434.
43. Meilandt WJ, Yu GQ, Chin J, Roberson ED, Palop JJ, Wu T et al (2008). Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease. J Neurosci 28: 5007-5017.
44. Mintzer MZ, Copersino ML, Stitzer ML (2005). Opioid abuse and cognitive performance. Drug Alcohol Depend 78: 225-230.
45. Nestler EJ (2002). Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem 78: 637-647.
46. O'Brien RJ, Kamboj S, Ehlers MD, Rosen KR, Fischbach GD, Huganir RL (1998). Activity-dependent modulation of synaptic AMPA receptor accumulation. Neuron 21: 1067-1078.
47. Prudic J, Fitzsimons L, Nobler MS, Sackeim HA (1999). Naloxone in the prevention of the adverse cognitive effects of ECT: a within-subject, placebo controlled study. Neuropsycho pharmacology 21: 285-293.
48. Rang HP, Dale MM, Ritter JM, Gardner P (1995). Analgesic Drugs. Chapter 31 Pharmacology 3rd edn. Churchill Livingstone Inc., 609-633 ISBN 0-443-07560-3.
49. Robinson TE, Gorny G, Savage VR, Kolb B (2002). Widespread but regionally specific effects of experimenter-versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse 46: 271-279.
50. Schumann H, Erickson T, Thompson TM, Zautcke JL, Denton JS (2008). Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. Clin Toxicol (Phila) 46: 501-506.
51. Silbert BS, Scott DA, Evered LA, Lewis MS, Kalpokas M, Maruff P et al (2006). A comparison of the effect of high- and low-dose fentanyl on the incidence of postoperative cognitive dysfunction after coronary artery bypass surgery in the elderly. Anesthesiology 104: 1137-1145.
52. Skaer TL (2004). Practice guidelines for transdermal opioids in malignant pain. Drugs 64: 2629-2638.
53. Skaer TL (2006). Transdermal opioids for cancer pain. Health Qual Life Outcomes 4: 24.
54. Stanley TH (1992). The history and development of the fentanyl series. J Pain Symptom Manage 7(3 Suppl): S3-S7.
55. Stanley TH (2005). Fentanyl. J Pain Symptom Manage 29(5 Suppl): S67-S71.
56. Sternini C, Spann M, Anton B, Keith Jr DE, Bunnett NW, von Zastrow M et al (1996). Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc Natl Acad Sci USA 93: 9241-9246.
57. Trescot AM, Glaser SE, Hansen H, Benyamin R, Patel S, Manchikanti L (2008). Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician 11: S181-S200.
58. Trujillo KA, Akil H (1991). Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251: 85-87.
59. Vorel SR, Liu X, Hayes RJ, Spector JA, Gardner EL (2001). Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 292: 1175-1178.
60. Whistler JL, Chuang H, Chu P, Jan LY, von Zastrow M (1999). Functional dissociation of m opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23: 737-746.
61. Whistler JL, von Zastrow M (1998). Morphine-activated opioid receptors elude desensitization by β-arrestin. PNAS 95: 9914-9919.
62. Wiens K, Lin H, Liao D (2005). Rac1 induces the clustering of AMPA receptors during spinogenesis. J Neurosci 25: 10627-10636.
63. Williams JT, Christie MJ, Manzoni O (2001). Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81: 299-343.
64. Wolf ME (2002). Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol Interv 2: 146-157.
65. Wolf ME, Jeziorski M (1993). Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 613: 291-294.
66. Zhao H, Loh HH, Law PY (2006). Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization. Mol Pharmacol 69: 1421-1432.